The Science behind our Technology

In the fast-evolving cannabinoids market, maintaining the potency of active agents is crucial. We are dedicated to preserving the therapeutic benefits of cannabinoid compounds, such as CBDA, THCA, CBGA, and CBCA.

Introducing @LDH™ Technology: Our patent-pending @LDH™ technology achieves over 90% encapsulation efficiency for acidic cannabinoids, ensuring maximum potency, stability, and long-term effectiveness.

Key Benefits Include:

• Long-Term Stability and Protection: 
  • @LDH selectively encases acidic cannabinoids (CBDA, THCA, CBGA, CBCA) to prevent degradation, ensuring accurate dosing and sustained product effectiveness. 
  • Strongly inhibits the formation of degradants, including scheduled compounds like       Δ-9 tetrahydrocannabinol (THC).
• THCA Stability and Non-Psychoactive Properties: 
  • THCA does not convert to Δ-9 in vivo; it metabolizes into 11-hydroxy molecules       without psychotropic effects.
• Processable and Scalable Formulation: 
  • The combination of @LDH technology and acidic cannabinoids produces a fine       powder from inexpensive, considered safe (GRAS) excipients.
  • Validated scalability ensures efficient production.
• Versatile Delivery and Administration: 
  • The finished product can be used in various delivery systems and administration routes, including dispersions, emulsions, injectables, sublingual, oral, and inhalation.
  • @LDH technology provides taste and smell masking, enhancing user experience.
• Regulatory-Friendly Formulation: 
  • Avoids creating new chemical entities (NCEs), expedites market entry, and       efficiently navigates regulatory obstacles.
  • GRAS formulation.
  • @LDH technology allows production flexibility regarding equipment and starting materials. 
• Temperature Resilience: 
  • Eliminates the need for complex cold storage by providing unparalleled protection       from elevated temperatures.
• Prevention of Degradation: 
  • Prevents decarboxylation and oxidation.
• Precise Dosing: 
  • Ensures accurate and consistent dosing.

Our formulation employs cost-effective GRAS ingredients and standard pharmaceutical processes, resulting in @LDH™ intercalated material. These intercalates ensure efficient delivery, can be tailored for various administration routes, and meet stringent regulatory standards.